General Information of Drug Off-Target (DOT) (ID: OTHOACHD)

DOT Name Metallothionein-2 (MT2A)
Synonyms MT-2; Metallothionein-2A; Metallothionein-II; MT-II
Gene Name MT2A
UniProt ID
MT2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
1MHU; 2MHU
Pfam ID
PF00131
Sequence
MDPNCSCAAGDSCTCAGSCKCKECKCTSCKKSCCSCCPVGCAKCAQGCICKGASDKCSCC
A
Function Metallothioneins have a high content of cysteine residues that bind various heavy metals; these proteins are transcriptionally regulated by both heavy metals and glucocorticoids.
KEGG Pathway
Mineral absorption (hsa04978 )
Reactome Pathway
Interferon gamma signaling (R-HSA-877300 )
Metallothioneins bind metals (R-HSA-5661231 )

Molecular Interaction Atlas (MIA) of This DOT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
This DOT Affected the Drug Response of 3 Drug(s)
Drug Name Drug ID Highest Status Interaction REF
Temozolomide DMKECZD Approved Metallothionein-2 (MT2A) affects the response to substance of Temozolomide. [60]
Paclitaxel DMLB81S Approved Metallothionein-2 (MT2A) increases the response to substance of Paclitaxel. [61]
DTI-015 DMXZRW0 Approved Metallothionein-2 (MT2A) affects the response to substance of DTI-015. [60]
------------------------------------------------------------------------------------
71 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Metallothionein-2 (MT2A). [1]
Ciclosporin DMAZJFX Approved Ciclosporin increases the expression of Metallothionein-2 (MT2A). [2]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Metallothionein-2 (MT2A). [3]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate increases the expression of Metallothionein-2 (MT2A). [4]
Cisplatin DMRHGI9 Approved Cisplatin increases the expression of Metallothionein-2 (MT2A). [5]
Estradiol DMUNTE3 Approved Estradiol decreases the expression of Metallothionein-2 (MT2A). [6]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of Metallothionein-2 (MT2A). [7]
Arsenic DMTL2Y1 Approved Arsenic decreases the expression of Metallothionein-2 (MT2A). [8]
Quercetin DM3NC4M Approved Quercetin increases the expression of Metallothionein-2 (MT2A). [9]
Arsenic trioxide DM61TA4 Approved Arsenic trioxide decreases the expression of Metallothionein-2 (MT2A). [10]
Hydrogen peroxide DM1NG5W Approved Hydrogen peroxide increases the expression of Metallothionein-2 (MT2A). [11]
Triclosan DMZUR4N Approved Triclosan increases the expression of Metallothionein-2 (MT2A). [12]
Decitabine DMQL8XJ Approved Decitabine increases the expression of Metallothionein-2 (MT2A). [13]
Marinol DM70IK5 Approved Marinol decreases the expression of Metallothionein-2 (MT2A). [14]
Zoledronate DMIXC7G Approved Zoledronate increases the expression of Metallothionein-2 (MT2A). [15]
Progesterone DMUY35B Approved Progesterone increases the expression of Metallothionein-2 (MT2A). [16]
Menadione DMSJDTY Approved Menadione increases the expression of Metallothionein-2 (MT2A). [11]
Fluorouracil DMUM7HZ Approved Fluorouracil decreases the expression of Metallothionein-2 (MT2A). [17]
Dexamethasone DMMWZET Approved Dexamethasone increases the expression of Metallothionein-2 (MT2A). [18]
Demecolcine DMCZQGK Approved Demecolcine increases the expression of Metallothionein-2 (MT2A). [19]
Niclosamide DMJAGXQ Approved Niclosamide increases the expression of Metallothionein-2 (MT2A). [20]
Cannabidiol DM0659E Approved Cannabidiol increases the expression of Metallothionein-2 (MT2A). [21]
Troglitazone DM3VFPD Approved Troglitazone increases the expression of Metallothionein-2 (MT2A). [22]
Cytarabine DMZD5QR Approved Cytarabine decreases the expression of Metallothionein-2 (MT2A). [23]
Etoposide DMNH3PG Approved Etoposide decreases the expression of Metallothionein-2 (MT2A). [17]
Piroxicam DMTK234 Approved Piroxicam decreases the expression of Metallothionein-2 (MT2A). [24]
Sodium lauryl sulfate DMLJ634 Approved Sodium lauryl sulfate increases the expression of Metallothionein-2 (MT2A). [25]
Malathion DMXZ84M Approved Malathion increases the expression of Metallothionein-2 (MT2A). [26]
Ethinyl estradiol DMODJ40 Approved Ethinyl estradiol increases the expression of Metallothionein-2 (MT2A). [27]
Cidofovir DMA13GD Approved Cidofovir increases the expression of Metallothionein-2 (MT2A). [28]
Ifosfamide DMCT3I8 Approved Ifosfamide increases the expression of Metallothionein-2 (MT2A). [28]
Methamphetamine DMPM4SK Approved Methamphetamine increases the expression of Metallothionein-2 (MT2A). [29]
Acetic Acid, Glacial DM4SJ5Y Approved Acetic Acid, Glacial increases the expression of Metallothionein-2 (MT2A). [30]
Motexafin gadolinium DMEJKRF Approved Motexafin gadolinium increases the expression of Metallothionein-2 (MT2A). [31]
Deoxycholic acid DM3GYAL Approved Deoxycholic acid increases the expression of Metallothionein-2 (MT2A). [32]
Dihydroxyacetone DMM1LG2 Approved Dihydroxyacetone decreases the expression of Metallothionein-2 (MT2A). [33]
Benzoic acid DMKB9FI Approved Benzoic acid increases the expression of Metallothionein-2 (MT2A). [34]
Gallium nitrate DMF9O6B Approved Gallium nitrate increases the expression of Metallothionein-2 (MT2A). [35]
Budesonide DMJIBAW Approved Budesonide increases the expression of Metallothionein-2 (MT2A). [36]
Promegestone DMK4S8I Approved Promegestone increases the expression of Metallothionein-2 (MT2A). [37]
Urethane DM7NSI0 Phase 4 Urethane increases the expression of Metallothionein-2 (MT2A). [38]
Dihydrotestosterone DM3S8XC Phase 4 Dihydrotestosterone decreases the expression of Metallothionein-2 (MT2A). [39]
SNDX-275 DMH7W9X Phase 3 SNDX-275 increases the expression of Metallothionein-2 (MT2A). [40]
Epigallocatechin gallate DMCGWBJ Phase 3 Epigallocatechin gallate decreases the expression of Metallothionein-2 (MT2A). [41]
Seocalcitol DMKL9QO Phase 3 Seocalcitol decreases the expression of Metallothionein-2 (MT2A). [42]
Genistein DM0JETC Phase 2/3 Genistein increases the expression of Metallothionein-2 (MT2A). [9]
Amiodarone DMUTEX3 Phase 2/3 Trial Amiodarone increases the expression of Metallothionein-2 (MT2A). [43]
DNCB DMDTVYC Phase 2 DNCB increases the expression of Metallothionein-2 (MT2A). [34]
Afimoxifene DMFORDT Phase 2 Afimoxifene increases the expression of Metallothionein-2 (MT2A). [44]
phorbol 12-myristate 13-acetate DMJWD62 Phase 2 phorbol 12-myristate 13-acetate increases the expression of Metallothionein-2 (MT2A). [45]
Disulfiram DMCL2OK Phase 2 Trial Disulfiram increases the expression of Metallothionein-2 (MT2A). [46]
ACYLINE DM9GRTK Phase 2 ACYLINE decreases the expression of Metallothionein-2 (MT2A). [47]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 increases the expression of Metallothionein-2 (MT2A). [49]
T83193 DMHO29Y Patented T83193 increases the expression of Metallothionein-2 (MT2A). [34]
Benzylcinnamate DMD7Z3H Patented Benzylcinnamate increases the expression of Metallothionein-2 (MT2A). [34]
Astemizole DM2HN6Q Withdrawn from market Astemizole increases the expression of Metallothionein-2 (MT2A). [32]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Metallothionein-2 (MT2A). [50]
chloropicrin DMSGBQA Investigative chloropicrin decreases the expression of Metallothionein-2 (MT2A). [51]
Deguelin DMXT7WG Investigative Deguelin increases the expression of Metallothionein-2 (MT2A). [52]
3R14S-OCHRATOXIN A DM2KEW6 Investigative 3R14S-OCHRATOXIN A increases the expression of Metallothionein-2 (MT2A). [53]
Paraquat DMR8O3X Investigative Paraquat increases the expression of Metallothionein-2 (MT2A). [54]
Nickel chloride DMI12Y8 Investigative Nickel chloride increases the expression of Metallothionein-2 (MT2A). [55]
Hexadecanoic acid DMWUXDZ Investigative Hexadecanoic acid decreases the expression of Metallothionein-2 (MT2A). [56]
Phencyclidine DMQBEYX Investigative Phencyclidine decreases the expression of Metallothionein-2 (MT2A). [57]
Lead acetate DML0GZ2 Investigative Lead acetate increases the expression of Metallothionein-2 (MT2A). [58]
Kaempferol DMHEMUB Investigative Kaempferol increases the expression of Metallothionein-2 (MT2A). [9]
Daidzein DMRFTJX Investigative Daidzein increases the expression of Metallothionein-2 (MT2A). [9]
biochanin A DM0HPWY Investigative biochanin A increases the expression of Metallothionein-2 (MT2A). [9]
hydroxycitronellal DMFHCV9 Investigative hydroxycitronellal increases the expression of Metallothionein-2 (MT2A). [34]
GW-788388 DMIBUW5 Investigative GW-788388 decreases the expression of Metallothionein-2 (MT2A). [43]
Genistein-7-glucoside DMMLNTW Investigative Genistein-7-glucoside increases the expression of Metallothionein-2 (MT2A). [59]
------------------------------------------------------------------------------------
⏷ Show the Full List of 71 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Metallothionein-2 (MT2A). [48]
------------------------------------------------------------------------------------

References

1 The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Toxicol Appl Pharmacol. 2009 Feb 15;235(1):124-34.
2 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
3 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
4 Differential metal response and regulation of human heavy metal-inducible genes. J Cell Physiol. 1999 Jul;180(1):105-13.
5 Expression pattern of cisplatin-induced metallothionein isoforms in squamous cell carcinoma. Anticancer Res. 2003 Jan-Feb;23(1A):299-303.
6 Human drug metabolism genes in parathion-and estrogen-treated breast cells. Int J Mol Med. 2007 Dec;20(6):875-81.
7 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
8 Blood metallothionein transcript as a biomarker for metal sensitivity: low blood metallothionein transcripts in arsenicosis patients from Guizhou, China. Environ Health Perspect. 2007 Jul;115(7):1101-6.
9 Expression of antioxidant proteins in human intestinal Caco-2 cells treated with dietary flavonoids. Cancer Lett. 1999 Nov 15;146(2):161-7.
10 Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells. Toxicol Appl Pharmacol. 2012 Jun 1;261(2):204-16.
11 Gene expression after treatment with hydrogen peroxide, menadione, or t-butyl hydroperoxide in breast cancer cells. Cancer Res. 2002 Nov 1;62(21):6246-54.
12 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
13 The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet. 2009 Feb;41(2):178-186.
14 JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells. Oncogene. 2008 Aug 28;27(37):5033-44.
15 Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
16 Gene expression in endometrial cancer cells (Ishikawa) after short time high dose exposure to progesterone. Steroids. 2008 Jan;73(1):116-28.
17 Identification of XAF1-MT2A mutual antagonism as a molecular switch in cell-fate decisions under stressful conditions. Proc Natl Acad Sci U S A. 2017 May 30;114(22):5683-5688. doi: 10.1073/pnas.1700861114. Epub 2017 May 15.
18 The aryl hydrocarbon receptor and glucocorticoid receptor interact to activate human metallothionein 2A. Toxicol Appl Pharmacol. 2013 Nov 15;273(1):90-9.
19 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
20 Computational discovery of niclosamide ethanolamine, a repurposed drug candidate that reduces growth of hepatocellular carcinoma cells initro and in mice by inhibiting cell division cycle 37 signaling. Gastroenterology. 2017 Jun;152(8):2022-2036.
21 Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma. Sci Rep. 2020 Nov 26;10(1):20622. doi: 10.1038/s41598-020-77674-y.
22 Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model. Toxicol In Vitro. 2009 Oct;23(7):1387-95.
23 Cytosine arabinoside induces ectoderm and inhibits mesoderm expression in human embryonic stem cells during multilineage differentiation. Br J Pharmacol. 2011 Apr;162(8):1743-56.
24 Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma. PLoS One. 2011;6(8):e23569.
25 CXCL14 downregulation in human keratinocytes is a potential biomarker for a novel in vitro skin sensitization test. Toxicol Appl Pharmacol. 2020 Jan 1;386:114828. doi: 10.1016/j.taap.2019.114828. Epub 2019 Nov 14.
26 Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. Int J Mol Sci. 2023 Mar 26;24(7):6259. doi: 10.3390/ijms24076259.
27 The metallohormone cadmium modulates AhR-associated gene expression in the small intestine of rats similar to ethinyl-estradiol. Arch Toxicol. 2013 Apr;87(4):633-43.
28 Transcriptomics hit the target: monitoring of ligand-activated and stress response pathways for chemical testing. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):7-18.
29 Complex role of zinc in methamphetamine toxicity in vitro. Neuroscience. 2010 Nov 24;171(1):31-9.
30 Motexafin gadolinium and zinc induce oxidative stress responses and apoptosis in B-cell lymphoma lines. Cancer Res. 2005 Dec 15;65(24):11676-88.
31 Motexafin gadolinium disrupts zinc metabolism in human cancer cell lines. Cancer Res. 2005 May 1;65(9):3837-45.
32 Identification of novel activators of the metal responsive transcription factor (MTF-1) using a gene expression biomarker in a microarray compendium. Metallomics. 2020 Sep 23;12(9):1400-1415. doi: 10.1039/d0mt00071j.
33 The sunless tanning agent dihydroxyacetone induces stress response gene expression and signaling in cultured human keratinocytes and reconstructed epidermis. Redox Biol. 2020 Sep;36:101594. doi: 10.1016/j.redox.2020.101594. Epub 2020 May 29.
34 A new in vitro method for identifying chemical sensitizers combining peptide binding with ARE/EpRE-mediated gene expression in human skin cells. Cutan Ocul Toxicol. 2010 Sep;29(3):171-92.
35 Role of oxidative stress in the induction of metallothionein-2A and heme oxygenase-1 gene expression by the antineoplastic agent gallium nitrate in human lymphoma cells. Free Radic Biol Med. 2008 Sep 15;45(6):763-72.
36 Interaction between glucocorticoids and beta2-agonists: alpha and beta glucocorticoid-receptor mRNA expression in human bronchial epithelial cells. Biochem Pharmacol. 1998 Dec 15;56(12):1561-9.
37 Short-chain fatty acids enhance nuclear receptor activity through mitogen-activated protein kinase activation and histone deacetylase inhibition. Proc Natl Acad Sci U S A. 2004 May 4;101(18):7199-204.
38 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
39 Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor alpha and beta. J Cell Physiol. 2011 May;226(5):1334-9.
40 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
41 Dietary catechins and procyanidins modulate zinc homeostasis in human HepG2 cells. J Nutr Biochem. 2011 Feb;22(2):153-63.
42 Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Mol Endocrinol. 2002 Jun;16(6):1243-56.
43 Capturing time-dependent activation of genes and stress-response pathways using transcriptomics in iPSC-derived renal proximal tubule cells. Cell Biol Toxicol. 2023 Aug;39(4):1773-1793. doi: 10.1007/s10565-022-09783-5. Epub 2022 Dec 31.
44 Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF. EMBO J. 2009 Mar 4;28(5):523-32.
45 Depletion of the cellular levels of Bag-1 proteins attenuates phorbol ester-induced downregulation of IB and nuclear accumulation of NF-B. Biochem Biophys Res Commun. 2010 Oct 22;401(3):406-11. doi: 10.1016/j.bbrc.2010.09.067. Epub 2010 Sep 19.
46 High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth. Clin Cancer Res. 2009 Oct 1;15(19):6070-8.
47 Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer. Cancer Res. 2007 May 15;67(10):5033-41.
48 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
49 CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer. J Clin Invest. 2016 Feb;126(2):639-52.
50 Low dose of bisphenol a modulates ovarian cancer gene expression profile and promotes epithelial to mesenchymal transition via canonical Wnt pathway. Toxicol Sci. 2018 Aug 1;164(2):527-538.
51 Transcriptomic analysis of human primary bronchial epithelial cells after chloropicrin treatment. Chem Res Toxicol. 2015 Oct 19;28(10):1926-35.
52 Neurotoxicity and underlying cellular changes of 21 mitochondrial respiratory chain inhibitors. Arch Toxicol. 2021 Feb;95(2):591-615. doi: 10.1007/s00204-020-02970-5. Epub 2021 Jan 29.
53 Intracellular zinc stores protect the intestinal epithelium from Ochratoxin A toxicity. Toxicol In Vitro. 2009 Dec;23(8):1516-21.
54 Differential induction of Mn-containing superoxide dismutase by paraquat in peripheral lymphocytes of normal subjects and gastric cancer patients. Mol Cells. 2003 Aug 31;16(1):13-8.
55 Zerovalent Fe, Co and Ni nanoparticle toxicity evaluated on SKOV-3 and U87 cell lines. J Appl Toxicol. 2016 Mar;36(3):385-93.
56 Identification of palmitate-regulated genes in HepG2 cells by applying microarray analysis. Biochim Biophys Acta. 2007 Sep;1770(9):1283-8. doi: 10.1016/j.bbagen.2007.07.001. Epub 2007 Jul 10.
57 Differential response of Mono Mac 6, BEAS-2B, and Jurkat cells to indoor dust. Environ Health Perspect. 2007 Sep;115(9):1325-32.
58 Analysis of lead toxicity in human cells. BMC Genomics. 2012 Jul 27;13:344.
59 Water-soluble genistin glycoside isoflavones up-regulate antioxidant metallothionein expression and scavenge free radicals. J Agric Food Chem. 2006 May 31;54(11):3819-26.
60 Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas. J Clin Oncol. 2006 Jan 10;24(2):274-87. doi: 10.1200/JCO.2005.02.9405. Epub 2005 Dec 19.
61 cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance. Breast Cancer Res Treat. 2006 Mar;96(1):17-39. doi: 10.1007/s10549-005-9026-6. Epub 2005 Dec 2.